Trials / Conditions / Neovascular (Wet) Age-related Macular Degeneration (AMD)
Neovascular (Wet) Age-related Macular Degeneration (AMD)
5 registered clinical trials studyying Neovascular (Wet) Age-related Macular Degeneration (AMD) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | A Long-term Follow up Study of EXG102-031 in Patients With wAMD (Everest LTFU) NCT06817343 | Exegenesis Bio | Phase 1 |
| Completed | A Study to Understand Effectiveness and Safety of ABP 938 Compared to Aflibercept (Eylea®) in Patients Sufferi NCT04270747 | Amgen | Phase 3 |
| Completed | Stereotactic Radiotherapy for Wet AMD (STAR) NCT02243878 | King's College Hospital NHS Trust | Phase 3 |
| Recruiting | OCT Angiography in Wet AMD NCT02253030 | Oregon Health and Science University | — |
| Completed | Phase 1 Safety Study With Intravitreal (IVT) REGN2176-3 in Patients Aged 50 Years and Older With Wet AMD NCT02061865 | Regeneron Pharmaceuticals | Phase 1 |